HUTCHMED to Announce 2022 Final Results

HUTCHMED to Announce 2022 Final Results

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Jan. 31, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13)......

Gentherm to Host Enhanced Earnings Call with Strategic

Gentherm to Host Enhanced Earnings Call with Strategic

NORTHVILLE, Mich., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic......

Sprouts Farmers Market to Report Fourth Quarter and Full

Sprouts Farmers Market to Report Fourth Quarter and Full

PHOENIX, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Sprouts Farmers Market, Inc. (Nasdaq: SFM) today announced it will issue financial results for the fourth......

Northrim BanCorp, Inc. Appoints Marilyn F. Romano to its

Northrim BanCorp, Inc. Appoints Marilyn F. Romano to its

ANCHORAGE, Alaska, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) announced that Marilyn F. Romano has been appointed to the......

Clover Health to Report Fourth Quarter and Full Year 2022

Clover Health to Report Fourth Quarter and Full Year 2022

FRANKLIN, Tenn., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a......

RGC Resources, Inc. Schedules First Quarter 2023 Earnings

RGC Resources, Inc. Schedules First Quarter 2023 Earnings

ROANOKE, Va., Jan. 30, 2023 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (NASDAQ: RGCO) will host its quarterly conference call and webcast to review the......

Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO

Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO

BERKELEY HEIGHTS, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a......

Aprea Therapeutics Appoints John Hamill as Chief Financial

Aprea Therapeutics Appoints John Hamill as Chief Financial

DOYLESTOWN, Pa., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing novel......

Destination XL Group, Inc. Names Dara Pauker Chief

Destination XL Group, Inc. Names Dara Pauker Chief

CANTON, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of men’s Big + Tall......

Daseke Names Adrianne D. Griffin Vice President, Investor

Daseke Names Adrianne D. Griffin Vice President, Investor

Newly created role with a dedicated proven leader facilitates enhanced communication of the Company’s shareholder value proposition......

  • 1
  • ...
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • menu
    menu